NEWARK, Del.--(BUSINESS WIRE)--Strategic Diagnostics Inc. (Nasdaq:SDIX) - a biotechnology company providing sophisticated antibody-based reagents to the life sciences industry and a leading provider of analytical test kits for a broad range of biomedical, food, water, agricultural, industrial and environmental applications, today announced that it has elected C. Geoffrey Davis, Ph.D. to its Board of Directors.
